News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,359 Results
Type
Article (1292)
Company Profile (15)
Press Release (85052)
Section
Business (24510)
Career Advice (132)
Deals (8834)
Drug Delivery (1)
Drug Development (8268)
Employer Resources (2)
FDA (1723)
Job Trends (1707)
News (43908)
Policy (3276)
Tag
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2026 Pharm Country Premier (1)
Academia (117)
Allergies (2)
Alliances (6617)
ALS (8)
Alzheimer's disease (140)
Antibody-drug conjugate (ADC) (4)
Approvals (1744)
Artificial intelligence (6)
Automation (2)
Bankruptcy (89)
Best Places to Work (1516)
Biosimilars (15)
Biotechnology (9)
Bladder cancer (4)
Brain cancer (2)
Breast cancer (22)
Cancer (216)
Cardiovascular disease (7)
Career advice (113)
CAR-T (7)
Cell therapy (29)
Cervical cancer (4)
Clinical research (7094)
Collaboration (71)
Compensation (57)
COVID-19 (108)
C-suite (28)
Cystic fibrosis (11)
Data (245)
Depression (3)
Diabetes (25)
Diagnostics (717)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (3)
Duchenne muscular dystrophy (3)
Earnings (8918)
Employer branding (1)
Employer resources (2)
Events (12010)
Executive appointments (112)
FDA (1868)
Featured Employer (5)
Frontotemporal dementia (1)
Funding (97)
Gene editing (3)
Gene therapy (15)
GLP-1 (26)
Government (227)
Guidances (6)
Healthcare (2214)
Immunology and inflammation (5)
Indications (2)
Infectious disease (118)
Inflammatory bowel disease (16)
Influenza (5)
Intellectual property (11)
Interviews (24)
IPO (5059)
Job creations (233)
Job search strategy (96)
Layoffs (13)
Legal (987)
Liver cancer (3)
Lung cancer (36)
Lymphoma (11)
Manufacturing (17)
MASH (6)
Medical device (2132)
Medtech (2132)
Mergers & acquisitions (4041)
Metabolic disorders (48)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (193)
NextGen: Class of 2025 (1008)
Non-profit (205)
Northern California (300)
Obesity (17)
Opinion (3)
Ovarian cancer (8)
Pain (15)
Pancreatic cancer (17)
Parkinson's disease (20)
Partnered (3)
Patents (36)
Patient recruitment (16)
Peanut (2)
People (7587)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (2059)
Phase II (3295)
Phase III (2450)
Pipeline (168)
Policy (1)
Postmarket research (179)
Preclinical (772)
Press Release (1)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (45)
Rare diseases (30)
Real estate (564)
Recruiting (1)
Regulatory (2269)
Reports (5)
Research institute (152)
Resumes & cover letters (15)
RSV (3)
Schizophrenia (10)
Series A (9)
Series B (11)
Sickle cell disease (8)
Southern California (339)
Spinal muscular atrophy (3)
Startups (551)
State (1)
Stomach cancer (1)
Supply chain (6)
United States (3478)
Vaccines (27)
Venture capitalists (1)
Weight loss (2)
Date
Today (3)
Last 7 days (75)
Last 30 days (300)
Last 365 days (4564)
2025 (1306)
2024 (5153)
2023 (6314)
2022 (7802)
2021 (8897)
2020 (8361)
2019 (5890)
2018 (4584)
2017 (4500)
2016 (3718)
2015 (5158)
2014 (3535)
2013 (2892)
2012 (3059)
2011 (2689)
2010 (2421)
Location
Africa (25)
Alabama (3)
Arizona (24)
Arkansas (1)
Asia (4500)
Australia (574)
California (830)
Canada (189)
China (37)
Colorado (21)
Connecticut (50)
Delaware (13)
Europe (6523)
Florida (155)
Georgia (48)
Idaho (7)
Illinois (60)
India (2)
Indiana (57)
Japan (14)
Kansas (20)
Kentucky (1)
Maine (35)
Maryland (106)
Massachusetts (556)
Michigan (78)
Minnesota (45)
Mississippi (2)
Missouri (11)
Montana (2)
Nebraska (3)
Nevada (23)
New Hampshire (9)
New Jersey (290)
New Mexico (2)
New York (307)
North Carolina (207)
Northern California (300)
Ohio (50)
Oregon (2)
Pennsylvania (209)
Rhode Island (4)
South America (72)
South Carolina (6)
Southern California (339)
Tennessee (34)
Texas (166)
Utah (43)
Virginia (24)
Washington D.C. (1)
Washington State (67)
West Virginia (1)
Wisconsin (12)
86,359 Results for "allegro ophthalmics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allegro’s injectable osteoarthritis treatment generates positive safety results in preclinical studies
March 25, 2025
·
3 min read
Press Releases
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
April 11, 2025
·
4 min read
Press Releases
Allegro reports positive safety data for its injectable osteoarthritis treatment in three preclinical studies
March 4, 2025
·
3 min read
Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research
January 27, 2025
·
3 min read
Biotech Beach
Allegro Ophthalmics Announces Presentation of Key Data Surrounding Dry AMD Pipeline Candidates, Treatment Considerations
Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel oxidative stress stabilizers for the treatment of ocular diseases, today announced the presentation of key data supporting dry AMD pipeline candidates, including the company’s risuteganib (Luminate®), this morning at Bascom Palmer Eye Institute’s 20th annual Angiogenesis, Exudation and Degeneration meeting.
February 10, 2023
·
3 min read
Drug Development
Allegro Ophthalmics Receives FDA Agreement Under Special Protocol Assessment (SPA) for Phase 2b/3 Clinical Trial of Risuteganib for the Treatment of Intermediate Dry AMD
Allegro Ophthalmics, LLC today announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for the design of its Phase 2b/3 clinical trial of risuteganib (Luminate®) for the treatment of intermediate, non-exudative age-related macular degeneration (dry AMD).
April 12, 2023
·
3 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
LSL PHARMA GROUP ANNOUNCES THE SIGNING OF TWO AGREEMENTS TO MARKET NEW OPHTHALMIC PRODUCTS IN CANADA
April 3, 2025
·
1 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
1 of 8,636
Next
